Technical analyses - HIKMA PHARMACEUTICALS ORD SHS 10P
You are currently viewing all technical analyses of the financial instrument HIKMA PHARMACEUTICALS ORD SHS 10P regarding all markets in all languages regarding all markets, sorted by Latest comments.
Sort : Latest comments | Latest posted
HIKMA PHARMACEUTICALS ORD SHS 10P
> Analyses
Thank you
Reply
Chart
Lutessia
has published a new analysis for Vincent Launay.
- 0
- 108788
- 30226
- 0
Timeframe : Daily - Simple chart
Status : INVALID
HIKMA PHARMACEUTICALS ORD SHS 10P
> Analyses
Thank you
Reply
Chart
Athenia
has published a new analysis for Vincent Launay.
- 0
- 26641
- 8725
- 0
Timeframe : Daily - Simple chart
Status : NEUTRAL
HIKMA PHARMACEUTICALS ORD SHS 10P
> Analyses
Thank you
Reply
Chart
Berolinia
has published a new analysis for Vincent Launay.
- 0
- 40846
- 9223
- 0
Timeframe : Daily - Simple chart
Status : INVALID
HIKMA PHARMACEUTICALS ORD SHS 10P
> Analyses
Thank you
Reply
Chart
Londinia
has published a new analysis for Vincent Launay.
- 0
- 70111
- 15090
- 0
Timeframe : Daily - Simple chart
Status : TARGET REACHED
The current short-term bearish acceleration registered on HIKMA PHARMACEUTICALS ORD SHS 10P should quickly allow the basic trend to return to a bearish trend. To avoid contradicting the short term,
HIKMA PHARMACEUTICALS ORD SHS 10P
> Analyses
Thank you
Reply
Chart
Madritia
has published a new analysis for Vincent Launay.
- 0
- 43505
- 9301
- 0
Timeframe : Daily - Simple chart
Status : INVALID
HIKMA PHARMACEUTICALS ORD SHS 10P
> Analyses
Thank you
Reply
Chart
Romia
has published a new analysis for Vincent Launay.
- 0
- 35993
- 9259
- 0
Timeframe : Daily - Simple chart
Status : INVALID
HIKMA PHARMACEUTICALS ORD SHS 10P
> Analyses
Thank you
Reply
Chart
Londinia
has published a new analysis for Vincent Launay.
- 0
- 70111
- 15090
- 0
Timeframe : Daily - Simple chart
Status : TARGET REACHED
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on HIKMA PHARMACEUTICALS ORD SHS 10P as long as the price remains well above